Delivery Order SPE2DB22D3401-SPE2DB25FT1WT
Award Date
1/31/25
Potential Completion Date
2/24/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,566.40 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, with an ultimate completion date of October 21, 2022. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $16,386.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of RYANODEX 250MG VIAL 1S, a pharmaceutical product, with a completion date of November 8, 2024. The award is not associated with a set-aside program and is a firm-fixed-price delivery order contract. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $4,816.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a specific medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 21, 2025. The contract award is not designated with a set-aside requirement, indicating an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,632.64 and is a Firm Fixed Price Delivery Order for the supply of RYANODEX 250 MG VIALS. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUPM0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,421.76 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a medical product, with a period of performance ending on February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM5G7 and a ceiling value of $24,081.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, to support federal government agencies. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $1,605.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of RYANODEX 250 MG VIALS. The award was made on January 27, 2025, with a completion date of February 18, 2025, and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, particularly within...
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, awarded to AmerisourceBergen Drug Corp's Corporate Office Division, has a ceiling value of $5,958.56 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant...
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the U.S. Department of Defense (DoD) and its agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and supplier to the federal government. The contract, valued at $4,468.92, was awarded on June 10, 2024 and has a performance period through July 2, 2024. It is a firm fixed-price delivery order contract with the DoD's Medical Supply Chain, also known as the Defense...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,027.20, is for the delivery of RYANODEX 250 MG VIALS, a medical product, and has a period of performance ending on February 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. AmerisourceBergen Drug...